Xiaoyong Song
Taiyuan, 030000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dihydroartemisinin promotes ABCG5/G8-mediated cholesterol efflux to potentiate anti-PD-1 therapy through YAP1-TEAD1 complex disruption in hepatocellular carcinoma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 21, 2026
Wolfberry prevented liver damage caused by anti-tuberculosis drugs associated with the YAP1/FXR pathway through gut microbiota.
Journal: Frontiers in microbiology
Published: September 08, 2025
Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: July 02, 2025
Dihydroartemisinin inhibits histone lactylation through YAP1 to act as a 'hot' switch for 'cold' tumor in hepatocellular carcinoma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 29, 2025
Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and upregulating GLYAT.
Journal: Journal of ethnopharmacology
Published: June 13, 2025
Lycium barbarum and Lactobacillus acidophilus synergistically protect against anti-tuberculosis drug-induced male reproductive injury via gut microbiota-independent pathways in mice.
Journal: Frontiers in microbiology
Published: May 02, 2025
Dihydroartemisinin inhibited tongue squamous cell carcinoma progression and tongue-to-lymph node metastasis through inhibiting RalB expression.
Journal: Acta histochemica
Published: October 21, 2024
RalB promotes lymph node metastasis in tongue squamous cell carcinoma.
Journal: Genes & genomics
Published: October 05, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026